Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Hickman

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2019
Discovery and preclinical characterization of [<sup>18</sup>F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathiesHeiko Kroth, Felix Oden, Jerome Molette, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic miceAndreas Muhs, David T Hickman, Maria Pihlgren, et al.
Blood|November 13, 2012
TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in miceMaria Pihlgren, Alberto B Silva, Rime Madani, et al.
Ebiomedicine|September 19, 2025
Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled studyOlivier Sol, Julien Mermoud, Merja Hallikainen, et al.
Plos One|March 30, 2016
An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down SyndromePavel V Belichenko, Rime Madani, Lorianne Rey-Bellet, et al.
Plos One|May 12, 2025
Correction: An Anti-β-Amyloid vaccine for treating cognitive deficits in a mouse model of down syndromePavel V Belichenko, Rime Madani, Lorianne Rey-Bellet, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2019
Discovery and preclinical characterization of [<sup>18</sup>F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathiesHeiko Kroth, Felix Oden, Jerome Molette, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic miceAndreas Muhs, David T Hickman, Maria Pihlgren, et al.
Blood|November 13, 2012
TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in miceMaria Pihlgren, Alberto B Silva, Rime Madani, et al.
Ebiomedicine|September 19, 2025
Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled studyOlivier Sol, Julien Mermoud, Merja Hallikainen, et al.
Plos One|March 30, 2016
An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down SyndromePavel V Belichenko, Rime Madani, Lorianne Rey-Bellet, et al.
Plos One|May 12, 2025
Correction: An Anti-β-Amyloid vaccine for treating cognitive deficits in a mouse model of down syndromePavel V Belichenko, Rime Madani, Lorianne Rey-Bellet, et al.
Pageof 2